Monoclonal antibody therapy for prevention of severe disease in nosocomial COVID-19

• Asıl Yazarlar: Adam Zimilover (Yazar), Thien-Ly Doan (Yazar), Sumeet Jain (Yazar), Prashant Malhotra (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: Cambridge University Press, 2022-07-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Background: In November 2020, the FDA issued an emergency use authorization (EUA) for monoclonal antibodies (mAbs) to be used in outpatients with COVID-19 infections who are at a high risk of progressing to severe disease. However, becuase the EUA had limited indications for inpatients, data on thei...